CDC advisory panel debates next steps in Johnson & Johnson vaccinations, makes no decision yet

CDC advisory panel debates next steps in Johnson & Johnson vaccinations, makes no decision yet
Johnson & Johnson
and last updated 2021-04-14 17:36:57-04
A CDC advisory panel debated possible next steps in the administration of the Johnson & Johnson COVID-19 vaccine, and after hours of questions and presentation, decided Wednesday they did not have enough information about the rare instances of blood clots to make a recommendation.
The Advisory Committee on Immunization Practices held an emergency meeting Wednesday afternoon to review what is known about the six reported cases of blood clots out of the 7 million vaccinations of the Johnson & Johnson COVID-19 vaccine.

Related Keywords

United States ,America ,Johnson ,Advisory Committee On Immunization Practices ,Advisory Committee ,Immunization Practices ,Advisory Panel On Immunization Practices ,Cdc Panel Debates Johnson And Covid 19 Vaccine ,Immunization Advisory Panel On The Future Ofj Ampj Vaccinations ,Is The Johnson Amp Vaccine Safe ,What Did The Cdc Say About Janesen Vaccine ,ஒன்றுபட்டது மாநிலங்களில் ,அமெரிக்கா ,ஜான்சன் ,நோய்த்தடுப்பு ப்ர்யாக்டிஸஸ் ,இருக்கிறது தி ஜான்சன் ஆம்ப் தடுப்பூசி பாதுகாப்பானது ,